High-expression of transforming growth factor β1 and phosphorylation of extracellular signal-regulated protein kinase in vascular smooth muscle cells from aorta and renal arterioles of spontaneous hypertension rats

Clinical and Experimental Hypertension

Volumn 29, Issue 2, 2007, Pages 107-117

  Jing, Li ^a,b   Zhang, Jian Zhong ^b   Zhao, Lin ^b   Wang, Yi Li ^a   Guo, Feng Ying ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Aorta; Arteriole; Extracellular signal regulated kinase; Hypertension; Transforming growth factor 1; Vascular smooth muscle cell

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTERY ENDOTHELIUM; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; RAT; RENAL ARTERY; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; THORACIC AORTA; WESTERN BLOTTING;

ANIMALS; AORTA; BLOTTING, WESTERN; CHINA; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RENAL ARTERY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33847227976     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960701195447     Document Type: Article

References (27)

1. Xu C, Lee S, Singh TM, Sho E, Li X, Sho M, Masuda H, Zarins CK. Molecular mechanisms of aortic wall remodeling in response to hypertension. J Vasc Surg. 2001;33:570-578.
2. Diez J, Fortuno MA, Zalba G, Etayo JC, Fortuno A, Ravassa S, Beaumont J. Altered regulation of smooth muscle cell proliferation and apoptosis in small arteries of spontaneously hypertensive rats. Eur Heart J. 1998;19(Suppl. G):29-33.
3. Ikedo H, Tamaki K, Ueda S, Kato S, Fujii M, Ten Dijke P, Okuda S. Smad protein and TGF-beta signaling in vascular smooth muscle cells. Int J Mol Med. 2003;11:645-650.
4. Enis DR, Shepherd BR, Wang Y, Qasim A, Shanahan CM, Weissberg PL, Kashgarian M, Pober JS, Schechner JS. Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells. Proc Natl Acad Sci USA. 2005;102:425-430.
5. Varagic J, Frohlich ED. Local cardiac rennin-angiotensin system: Hypertension and cardiac failure. J Mol Cell Cardiol. 2002;34:1435-1442.
6. Jing L, Zhang JZ, Lu HS, Guo FY, Qin J. The expression of extracellular signal-regulated kinase-2 (ERK-2) and c-jun in vascular smooth muscle cell in hypertensive rats. Chin J Hypertens. 2004;12:341-344 (in Chinese).
7. Landsberg L, Molitch M. Diabetes and hypertension: pathogenesis, prevention and treatment. Clin Exp Hypertens. 2004;26:621-628.
8. Kingsley K, Plopper GE. Platelet-derived growth factor modulates rat vascular smooth muscle cell responses on laminin-5 via mitogen-activated protein kinase-sensitive pathways. Cell Commun Signal. 2005;3:2.
9. Cruzado MC, Risler NR, Miatello RM, Yao G, Schiffrin EL, Touyz RM. Vascular smooth muscle cell NAD (P) H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation. Am J Hypertens. 2005;18:81-87.
10. Peppel K, Zhang LS, Orman ES, Hagen PO, Amalfitano A, Brian L, Freedman NJ. Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms. Cardiovasc Res. 2005;65:674-682.
11. Gennaro G, Menard C, Michaud SE, Deblois D, Rivard A. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor. Circulation. 2004;110:3367-3371.
12. Touyz RM, He G, El Mabrouk M, Diep Q, Mardigyan V, Schiffrin EL. Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats. J Hypertens. 2001;19:553-559.
13. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinase. Science. 2002;298:1911-1912.
14. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest. 1992;90:456-461.
15. Sinha S, Heagerty AM, Shuttleworth CA, Kielty CM. Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury. Cardiovasc Res. 2002;53:971-983.
16. 1 suppress intimal hyperplasia in a rat model. J Clin Invest. 1994;93:1172-1178.
17. Shukla N, Rowe D, Hinton J, Angelini GD, Jeremy JY. Calcium and the replication of human vascular smooth muscle cells: studies on the activation and translocation of extracellular signal regulated kinase (ERK) and cyclin D1 expression. Eur J Pharmacol. 2005;509:21-30.
18. Li C, Xu Q. Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal. 2000;12:435-445.
19. 1 promoter activation: similarity to hyperglycaemia. Diabetologia. 2002;45:890-898.
20. Laviades C, Varo N, Diea J. Transforming growth factor beta in hypertensives with cardiorenal damage. Hypertension. 2000;36:517-522.
21. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev. 2001;81:999-1030.
22. Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol. 2002;118:211-215.
23. Cottone S, Mule G, Amato F, Riccobene R, Vadala A, Lorito MC, Raspanti F, Cerasola G. Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure. J Nephrol. 2002;15:643-648.
24. Derhaschnig U, Shehata M, Herkner H, Bur A, Woisetschlager C, Laggner AN, Hirschl MM. Increased levels of transforming growth factor-beta1 in essential hypertension. Am J Hypertens. 2002;15:207-211.
25. Lenhard SC, Nerurkar SS, Schaeffer TR, Mirabile RC, Boyce RW, Adams DF, Jucker BM, Willette RN. P38 MAPK inhibitors ameliorate target organ damage in hypertension, part 2: Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging. J Pharmacol Exp Therap. 2003;307:939-946.
26. Porreca E, Di Febbo C, Vitacolonna E, Baccante G, Di Castelnuovo A, Angelini A, Febo F, Di Nisio M, Cuccurullo F. Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin. Am J Hypertens. 2002;15:759-765.
27. Gendron G, Gobeil F Jr, Morin J, D'Orleans-Juste P, Regoli D. Contractile responses of aortae from WKY and SHR to vasoconstrictors. Clin Exp Hypertens. 2004;26:511-523.